Company profile

Mirnext is a Dutch biomedical company focusing on the discovery, validation and commercialization of miRNAs as novel biomarkers for cardiovascular disease. The company is developing actionable and cost-effective multi-marker tests to improve diagnostic routine and clinical management of heart failure and coronary artery disease. 
Read more

Supervisory Board

The Supervisory Board of Mirnext is composed of seasoned life-science professionals with extensive experience in setting up, managing and guiding start-up companies. The Supervisory board oversees the strategic, organizational policy making and operational activities of the Management Board.
Read more

Team
ACS Biomarker has an experienced management team with a strong scientific, commercial and financial background.
Read more
Careers

Mirnext is a Dutch biomedical company active in the field of cardiovascular risk assessment. The company focuses on the discovery and validation of cardiovascular biomarkers and assay development.
Read more

Bookmark and Share